Ubidecarenone nanoemulsified composite systems

International Journal of Pharmaceutics

Volumn 291, Issue 1-2, 2005, Pages 113-118

  Carli, F ^a   Chiellini, E E ^a   Bellich, B ^a   Macchiavelli, S ^a   Cadelli, G ^a  

^a Remedia Srl   (Italy)

Author keywords

Coenzyme Q10; Oral absorption; Solid double microemulsion; Stability; Sub micron droplets

Indexed keywords

UBIDECARENONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; MICROEMULSION; NANOEMULSIFIED COMPOSITE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 13544252645     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.07.048     Document Type: Conference Paper

References (17)

1. B.J. Aungst Novel formulations strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism J. Pharm. Sci. 82 1993 979 987
2. F. Carli, and E.E. Chiellini Int. Pat. Appl. WO03/013421 2003
3. R.L. Carr Evaluating flow properties of solids Chem. Eng. 72 1965 163 168
4. P.P. Costantinides Lipid microemulsion for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm. Res. 12 1985 161 172
5. G.M. Eccleston Microemulsion S. Swarbrick J.C. Boylan Encyclopedia of Pharmaceutical Technology 1992 Marcel Dekker New York pp. 375-421
6. Florence, Attwood (Eds.), 1998. Physicochemical Principles of Pharmacy, third ed., pp. 252-307.
7. K. Folkers Y. Yamamura Biomedical and Clinical Aspects of Coenzyme Q vol. 2 1980 Elsevier/North Holland Biomedical Press Amsterdam pp. 333-347
8. S. Greenberg, and W.H. Fishman Coenzyme Q10: a new drug for cardiovascular disease J. Clin. Pharmacol. 30 1990 590 608
9. A.J. Humberstone, and W.N. Charman Lipid-based vehicles for the oral delivery of poorly water soluble drugs Adv. Drug. Del. Rev. 25 1997 103 128
10. T. Lindmark, T. Nikkila, and P. Artusson Mechanism of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 monolayers J. Pharmacol. Exp. Ther. 275 1995 958 964
11. S. Nazzal, N. Guven, I.K. Reddy, and M.A. Khan Preparation and characterization of coenzyme Q10-Eudragit solid dispersion Drug Dev. Ind. Pharm. 28 2002 49 57
12. J.R. Robinson Introduction: semi-solid formulations for oral drug delivery Bull. Tech. Gattefossè 89 1996 11 13
13. N.H. Shah, M.T. Carvajal, C.I. Patel, M.H. Infeld, and A.W. Malick Self-emulsifying drug delivery systems (SEEDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs Int. J. Pharm. 106 1996 15 23
14. V. Scalori, M.G. Alessandrì, M. Mian, L. Giovannini, and A.A.E. Bertelli Plasma and tissue concentrations of coenzyme Q10 in the rat after its oral administration Int. J. Tissue React. 2 1998 95 97
15. E.S. Swenson, and W.J. Curatolo Means to enhance penetration Adv. Drug. Del. Rev. 8 1992 39 42
16. H. Takeuchi, H. Sasaki, T. Niwa, T. Hino, Y. Kawashima, K. Uesugi, and H. Ozawa Improvement of photostability of ubidecarenone in the formulation of a novel powdered dosage form termed redispersible dry emulsion Int. J. Pharm. 86 1992 25 33
17. B.D. Tarr, and S.H. Yalkowsky Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion of droplets size Pharm. Res. 6 1989 40 43